Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of GLP-1 Analogues for the Optimization of Outcomes in High BMI Patients Undergoing AbLation for Atrial Fibrillation

NCT05221229 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.

NCT NCT05221229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05221229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of GLP-1 Analogues for the Optimization of Outcomes in High BMI Patients Undergoing AbLation for Atrial Fibrillation
Lead sponsor
University Hospital Birmingham
Phase
Observational
Overall status
Active, not recruiting
Start date
April 17, 2022
Completion date
June 1, 2026
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, liraglutide, overweight and obesity, recurrence